Skip to main content
SpringerLink
Log in

Evaluation of antitumor drug side effects in small animals

  • Original Articles
  • Antitumor Drug Side Effects
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

This is an initial report on the development of screening tests for side effects of antitumor drugs, with small amounts of compound and short time intervals. These tests are based on acute dosing of mice and various blood or serum measurements: (a) total white blood cell count for leukopenia; (b) BUN for kidney toxicity; (c) SGPT for liver toxicity; and (d) creatine phosphokinase MB isozyme (CPK-MB) for cardiotoxicity. A correlation with the toxicity observed in other species is developed by establishing the effect of a prototype compound for each toxicity and tests of one or more compounds expected to lack such toxicity. On the basis of the limited number of compounds studied all four tests, although varying in sensitivity, seem to correlate with the results of tests in other species and with known effects in man. Final validation of these acute tests, especially the CPK-MB, will require both further study of histopathologic effects and correlation with results from clinical trials of an extended list of agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson T, McMenamin MB, Schein PS (1975) Chlorozotocin, 2-[3-(2-chloroethyl)-3-nitrosouriedo]-d-glucopyranose, an antitumor agent with modified bone marrow toxicity. Cancer Res 35:761

    Google Scholar 

  2. Avery TL, Roberts D, Price RA (1973) Delayed toxicity of 4′Demethylepipodophyllotoxin 9-(4,6-0-2-thenylidine-β-d-glycopyranoside) (NSC 122819; VM-26) in mice. Cancer Chemother Rep [1] 57:165

    Google Scholar 

  3. Bradner WT, Huftalen JB (1978) Marcellomycin: An anthracycline without leukopenic effect in BDF1 mice. Proc Am Assoc Cancer Res 19:46

    Google Scholar 

  4. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anti cancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219

    CAS  PubMed  Google Scholar 

  5. Goldsmith MA, Slavik M, Carter SK (1975) Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Res 35:1354

    Google Scholar 

  6. Guarino AM, Rozencweig M, Kline I, Penta JS, Venditti JM, Lloyd HH, Holzworth DA, Muggia FM (1979) Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents. Cancer Res 39:2204

    Google Scholar 

  7. Harrison SD, Jr, Burdeshaw JA, Crosby RG, Cusic AM, Denine EP (1978) Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice. Cancer Res 38:2636

    Google Scholar 

  8. Kociba RJ, Sleight SD (1977) Acute toxicology and pathologic effects of cis-diamminedichloroplatinum (NSC 119875) in the male rat. Cancer Chemother Rep [1] 55:1

    Google Scholar 

  9. Lenaz L, Sternberg SS, DeHarven E, Vidal PM, Philips FA (1978) Cardiac lesions in adriamycin treated mice. Proc Am Assoc Cancer Res 19:213

    Google Scholar 

  10. Olson HM, Capen CC (1977) Subacute cardiotoxicity of adriamycin in the rat: Biochemical and ultrastructural investigations. Lab Invest 37:386

    Google Scholar 

  11. Rakieten N, Nadkarni MV, Rakieten ML, Gordon BS (1969) Toxicologic and pharmacologic evaluation of phleomycin including special studies on its nephrotoxicity. Toxicol Appl Pharmacol 14:590

    Google Scholar 

  12. Rao PS, Lukes JJ, Ayers SM, Mueller H (1975) New manual and automated method for determining activity of creatine kinase isoenzymes MB by use of dithiothreitol: Clinical applications. Clin Chem 21:1612

    Google Scholar 

  13. Riley V (1960) Adaptation of orbital bleeding technic to rapid serial blood studies. Proc Soc Exp Biol Med 104:751

    Google Scholar 

  14. Rosenoff SH, Olson HM, Young DM, Bostick F, Young RC (1975) Adriamycin-induced cardiac damage in the mouse: A small-animal model of cardiotoxicity. J Natl Cancer Inst 55:191

    Google Scholar 

  15. Steel R, Torrie J (1960) Principles and procedures of statistics. McGraw-Hill, New York, p 72

    Google Scholar 

  16. Thompson G, Baker J, Fleischman R, Schaeppi U, Cooney D, Davis R (1970) Toxicity of bleomycin (NSC 125066), a new carcinostatic antibiotic, in dogs and monkeys. Pharmacologist 12:241

    Google Scholar 

  17. Thompson GR, Baker JR, Fleischman RW, Rosenkrantz H, Schaeppi UH, Cooney DA, Davis RD (1972) Preclinical toxicological evaluation of bleomycin (NSC-125066), a new antitumor antibiotic. Toxicol Appl Pharmacol 23:544

    Google Scholar 

  18. Weil CA (1952) Tables for convenient calculation of median effective dose (LD50 or ED50) and instructions for their use. Biometrics 8:249

    Google Scholar 

  19. Young DM (1975) Pathologic effects of adriamycin (NSC-123127) in experimental systems. Cancer Chemother Rep [3] 6:159

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Laboratories Division, Bristol-Myers Company, P.O. Box 657, 13201, Syracuse, NY, USA

    W. T. Bradner, J. E. Schurig, J. B. Huftalen & G. J. Doyle

Authors
  1. W. T. Bradner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. E. Schurig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. B. Huftalen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. J. Doyle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bradner, W.T., Schurig, J.E., Huftalen, J.B. et al. Evaluation of antitumor drug side effects in small animals. Cancer Chemother. Pharmacol. 4, 95–101 (1980). https://doi.org/10.1007/BF00254029

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254029

Keywords

Search

Navigation